A novel paper MAP method for rapid high resolution histological analysis

Male Proteome Science Nude Brain Neoplasms / metabolism Spinal Cord Injuries / pathology* 610 Mice, Nude Apoptosis Article Imaging Mice 03 medical and health sciences Imaging, Three-Dimensional Alzheimer Disease Tumor Cells, Cultured Animals Humans Alzheimer Disease / pathology* Glioblastoma / metabolism Spinal Cord Injuries Three-Dimensional / methods* Cell Proliferation Brain Neoplasms / pathology* Microscopy 0303 health sciences Cultured Microscopy, Confocal Brain Neoplasms Spinal Cord Injuries / metabolism Q R Brain Brain / metabolism* Xenograft Model Antitumor Assays Tumor Cells Alzheimer Disease / metabolism Confocal Medicine Proteome / analysis Proteome / metabolism* Glioblastoma / pathology* Glioblastoma
DOI: 10.1038/s41598-021-02632-1 Publication Date: 2021-12-02T11:03:04Z
ABSTRACT
AbstractThree-dimensional visualization of cellular and subcellular-structures in histological-tissues is essential for understanding the complexities of biological-phenomena, especially with regards structural and spatial relationships and pathologlical-diagnosis. Recent advancements in tissue-clearing technology, such as Magnified Analysis of Proteome (MAP), have significantly improved our ability to study biological-structures in three-dimensional space; however, their wide applicability to a variety of tissues is limited by long incubation-times and a need for advanced imaging-systems that are not readily available in most-laboratories. Here, we present optimized MAP-based method for paper-thin samples, Paper-MAP, which allow for rapid clearing and subsequent imaging of three-dimensional sections derived from various tissues using conventional confocal-microscopy. Paper-MAP successfully clear tissues within 1-day, compared to the original-MAP, without significant differences in achieved optical-transparency. As a proof-of-concept, we investigated the vasculature and neuronal-networks of a variety of human and rodent tissues processed via Paper-MAP, in both healthy and diseased contexts, including Alzheimer’s disease and glioma.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (34)
CITATIONS (2)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....